logo-loader

RESAAS, Pivotal Therapeutics and Plus8 Global Investor Evening, Toronto, June 6th, 5:30pm

Published: 08:35 30 May 2013 EDT

no_picture_pai

RESAAS, Pivotal Therapeutics and Plus8 Global Investor Evening, Toronto, June 6th, 5:30pm

Our next Proactive Investors One2One Forum, sponsored by the CNSX, will take place June 6th as we showcase another batch of exciting companies in Toronto. The event kicks off at 5:30 pm, in the East Ballroom at the Toronto Region Board of Trade - 77 Adelaide Street West.

Presenting will be the directors of RESAAS (CNSX:RSS), Pivotal Therapeutics (CNSX:PVO) and Plus8 Global (CNSX:PGT)

---Don't miss out and register for the event HERE---

RESAAS's social network is designed to allow real-time updating of property listings as well as the ability to sync with social media sites such as Facebook and Twitter. Known as real estate broadcasts, RESAAS' reblasts engine automatically generates all of an agency's real estate workflow into social content that is instantly pushed out to the RESAAS platform and other social networks.

The next CNSX-listed company on the list will be Pivotal Therapeutics, which recently revealed that results from a clinical trial showed that its Vascazen product was highly effective in correcting an Omega-3 deficiency.  Vascazen is an FDA-regulated medical food product developed to lower cardiovascular health risks in Omega-3 deficient cardiac patients, including high triglycerides, or fatty substances in the blood that are associated with coronary disease. The product is available with a prescription in all major pharmacies throughout the U.S.

Wrapping up our CNSX event will be recently listed Plus8 Global, which is in the midst of launching Trader|OS, a RealTime social collaborative charting and communication platform for investors. The Trader|OS Platform allows users to customize their layout, including the ability to launch a video to watch financial news. It also allows traders to follow and connect with other users, aggregate content, and share all this information, both on the platform and across their personal networks.

RESAAS, Pivotal Therapeutics and Plus8 Global will each make a 20 minute pitch followed by a 10 minute inquisition by a roomful of potential investors. Once the companies have presented, complimentary canapés and beverages are available for 90 minutes during a break-out session, where attendees can mingle with other guests, or ask more questions to the presenters.

We look forward to seeing you there! To find out more details and register for this event, please click HERE.

About Proactive Investors

In six years, Proactive Investors, a digital news and events business, has organized more than 300 events in Australia, Canada, Europe and USA, introducing investors to some of the stock market’s best-performing small and midcap companies.  Proactive Investors works with over 500 companies globally, through offices in Sydney, Toronto, New York and London.

To learn more visit https://www.proactiveinvestors.com or email action@proactiveinvestors.com

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

20 minutes ago